Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 9, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

The cachexia assessment scale: development and psychometric properties.

Rina Gabison1, Maya Gibbs, Beatrice Uziely

  • 1Oncology Palliative Care Unit, Clalit Health Services, Jerusalem, Israel.

Oncology Nursing Forum
|August 28, 2010
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patients' Experiences of Nurse-Led Integrative Palliative Care in Multiple Myeloma.

Cancer nursing·2026
Same author

Beyond Pain: An Exploratory Secondary Analysis of Psychological and Physical Discomfort Domains in ICU Patients.

Nursing in critical care·2026
Same author

Early Nurse-Led Integrated Palliative Care Intervention for Patients With Multiple Myeloma.

The American journal of hospice & palliative care·2026
Same author

Hematology nurses' perceptions of implementing primary palliative care for patients with multiple myeloma: A qualitative study.

European journal of oncology nursing : the official journal of European Oncology Nursing Society·2025
Same author

Measuring pain or discomfort during routine nursing care in lightly sedated mechanically ventilated intensive care patients: A prospective preliminary cohort study.

Heart & lung : the journal of critical care·2024
Same author

PH-binding motifs as a platform for drug design: Lessons from protease-activated receptors; PARs.

Oncoscience·2024
Same journal

Exploring Information Needs of Patients With Cancer and Family Caregivers: A Descriptive and Network Analysis of End-of-Life Inquiries.

Oncology nursing forum·2026
Same journal

Postoperative Physiologic Comfort Management for Patients With Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy.

Oncology nursing forum·2026
Same journal

Exploring Racial Disparities in Uterine Cancer Survival: A 20-Year, Single-Site Analysis.

Oncology nursing forum·2026
Same journal

What I See as an Editor: The Reach of Nurse-Led Intervention Oncology Research.

Oncology nursing forum·2026
Same journal

Trends and Hot Spots in Cancer Family Resilience: A Bibliometric and Visualization Study.

Oncology nursing forum·2026
Same journal

Seven-Year Cognitive Trajectories in Older Adult Cancer Survivors: Findings From a National Cohort Study.

Oncology nursing forum·2026
See all related articles

A new tool, the Cachexia Assessment Scale (CAS), accurately identifies cancer cachexia across all disease stages. This reliable and valid scale aids in patient assessment in diverse oncology settings.

Area of Science:

  • Oncology
  • Clinical Assessment
  • Psychometrics

Background:

  • Cancer cachexia is a complex syndrome impacting patients across all disease stages.
  • Accurate and reliable assessment tools are crucial for timely intervention.
  • Existing assessment methods may lack comprehensive evaluation across the continuum of cancer care.

Purpose of the Study:

  • To develop and validate a tool for identifying cancer cachexia in patients throughout all disease stages.
  • To create a reliable and valid instrument for assessing cachexia in oncology patients.

Main Methods:

  • A tool development study involving literature review to create the Cachexia Assessment Scale (CAS).
  • Psychometric testing of the CAS, including reliability (inter-rater, test-retest, internal consistency) and validity (content, criterion, sensitivity, specificity).

Related Experiment Videos

Last Updated: Jun 9, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

  • Study conducted across various oncology settings including day care, clinics, radiotherapy, and hospice care with 90 cancer patients.

    • Main Results:

    • The Cachexia Assessment Scale (CAS) demonstrated adequate reliability, including inter-rater, test-retest, and internal consistency.
    • The CAS exhibited sufficient validity, encompassing content validity, criterion validity, sensitivity, and specificity.
    • The scale is suitable for assessing the presence of cachexia in cancer patients.

    Conclusions:

    • The Cachexia Assessment Scale (CAS) is a reliable and valid tool for evaluating cancer cachexia.
    • The CAS can be effectively utilized for cachexia assessment in patients at all stages of cancer.
    • The scale is applicable across diverse clinical settings within cancer care, including hospice and radiotherapy.